ARTG 463893Clinical chemistry-specific protein IVDs
ARTG ID: 463893 · Abacus dx Pty Ltd · Response Biomedical Corporation · Class IIb · Started October 08, 2024
Good Name: Abacus dx Pty Ltd - Clinical chemistry-specific protein IVDs
- Risk Class
- Class IIb
- Product Type
- IVD
- ARTG Category
- IVD
- ARTG ID
- 463893
- Start Date
- October 08, 2024
- Effective Date
- October 08, 2024
- Country
- Canada
- Address
- 1781 75th Avenue West, Vancouver, British Col, V6P 6P2
IVDs that are intended to measure levels of protein biomarkers that, in conjunction with other laboratory findings and clinical assessment, aid in the diagnosis of cardiovascular events.
Access comprehensive regulatory information for Clinical chemistry-specific protein IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 463893 and sponsored by Abacus dx Pty Ltd, manufactured by Response Biomedical Corporation in Canada. The device registration started on October 08, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.